The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 25, 2022
Filed:
Mar. 05, 2019
Applicants:
Janssen Pharmaceutica NV, Beerse, BE;
James C. Lanter, Cambridge, MA (US);
Inventors:
James C. Lanter, Cambridge, MA (US);
Mark J. Macielag, Gwynedd Valley, PA (US);
Mark Wall, Lansdale, PA (US);
Michael P. Winters, Morgantown, PA (US);
Yue-Mei Zhang, Wellesley, MA (US);
Zhihua Sui, Norristown, PA (US);
Assignee:
Janssen Pharmaceutica NV, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/55 (2006.01); C07C 255/46 (2006.01); C07D 307/40 (2006.01); C07C 57/46 (2006.01); C07D 277/24 (2006.01); C07C 57/38 (2006.01);
U.S. Cl.
CPC ...
C07D 213/55 (2013.01); C07C 57/38 (2013.01); C07C 57/46 (2013.01); C07C 255/46 (2013.01); C07D 277/24 (2013.01); C07D 307/40 (2013.01);
Abstract
The present invention is directed to cycloalkenyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the GPR120 and/or GPR40 receptors. More particularly, the compounds of the present invention are agonists of GPR120 and/or GPR40, useful in the treatment of, for example, obesity, Type II Diabetes Mellitus, dyslipidemia, etc.